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Mutations in FLVCR1 Cause
Posterior Column Ataxia and Retinitis Pigmentosa
Anjali M. Rajadhyaksha,1,2,12 Olivier Elemento,3,12 Erik G. Puffenberger,5 Kathryn C. Schierberl,1,2
Jenny Z. Xiang,4 Maria L. Putorti,6 Jose´ Berciano,7 Chantal Poulin,8 Bernard Brais,6
Michel Michaelides,9,10,11 Richard G. Weleber,9 and Joseph J. Higgins1,*
The study of inherited retinal diseases has advanced our knowledge of the cellular andmolecularmechanisms involved in sensory neural
signaling. Dysfunction of two specific sensory modalities, vision and proprioception, characterizes the phenotype of the rare, auto-
somal-recessive disorder posterior column ataxia and retinitis pigmentosa (PCARP). Using targeted DNA capture and high-throughput
sequencing, we analyzed the entire 4.2 Mb candidate sequence on chromosome 1q32 to find the gene mutated in PCARP in a single
family. Employing comprehensive bioinformatic analysis and filtering, we identified a single-nucleotide coding variant in the feline
leukemia virus subgroup C cellular receptor 1 (FLVCR1), a gene encoding a heme-transporter protein. Sanger sequencing confirmed
the FLVCR1 mutation in this family and identified different homozygous missense mutations located within the protein’s transmem-
brane channel segment in two other unrelated families with PCARP. To determine whether the selective pathologic features of PCARP
correlated with FLVCR1 expression, we examined wild-typemouse Flvcr1mRNA levels in the posterior column of the spinal cord and the
retina via quantitative real-time reverse-transcriptase PCR. The Flvcr1 mRNA levels were most abundant in the retina, followed by the
posterior column of the spinal cord and other brain regions. These results suggest that aberrant FLVCR1 causes a selective degeneration
of a subpopulation of neurons in the retina and the posterior columns of the spinal cord via dysregulation of heme or iron homeostasis.
This finding broadens the molecular basis of sensory neural signaling to include common mechanisms that involve proprioception
and vision.Introduction
In 1997, Higgins et al.1 described a childhood-onset, auto-
somal-recessive, neurodegenerative syndrome with the
clinical features of sensory ataxia and retinitis pigmentosa
(posterior column ataxia and retinitis pigmentosa [PCARP])
(associated with the AXPC1 locus [MIM 609033]). PCARP
begins in infancy with areflexia and retinitis pigmentosa
(RP). Nyctalopia (night blindness) and peripheral visual-
field loss is usually evident during late childhood or teenage
years, with subsequent progressive constriction of the
visual fields and loss of central retinal function over time.
A sensory ataxia caused by degeneration of the posterior
columns of the spinal cord results in a loss of proprioceptive
sensation that is clinically evident in the second decade of
life and gradually progresses. Scoliosis, camptodactyly,
achalasia, gastrointestinal dysmotility, and a sensory
peripheral neuropathy are variable features of the disease.
Affected individuals have no clinical or radiological
evidence of cerebral or cerebellar involvement but may
demonstrate hyperintense signals in the posterior aspect
of the spinal cordon inversion recoveryMRI.1,2Neurophys-1Department of Pediatrics, Division of Pediatric Neurology, New York Presbyt
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The Americaniologic and histological evidence defines PCARP as a
sensory ganglionopathy causing a harmonious degenera-
tion of central and peripheral axons without evidence of
primary demyelination.1,3–5
Isolated, inherited, posterior column ataxia (MIM
176250) has been described in three families, but RP6 was
not a clinical feature.7,8 The index family was identified in
1939 by Mollaret and reported in 1951 by Biemond.7 The
cardinal clinical features were areflexia, proprioceptive
loss, and postmortem evidence of posterior column degen-
eration. Later, Singh et al.8 described another family with
posterior columnataxia but reported the additional features
of scoliosis and a peripheral demyelinating neuropathy.
Recently, an autosomal-dominant form of sensory ataxia
(MIM 608984) was described in a third family of Anglo-
Saxon ancestry living in Eastern Canada.9 The phenotype,
linked to chromosome 8p12-8q12, begins with a mild
sensory ataxia with moderate to severe pyramidal weak-
ness. Neuroimaging of the brain and spinal cord and nerve
conduction velocities were normal. In contrast to PCARP,
the disorder affects the preganglion sensory nerve fibers
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of the spinal cord. Some of the recessively inherited spino-
cerebellar ataxias are associated with RP,10 but the presence
of cerebellar signs, sensorineural hearing loss, and involve-
ment of pain and temperature sensory modalities distin-
guish these individuals from those with PCARP.
Screening for gene mutations at the AXPC1 locus on the
basis of the known or putative function of their proteins
(candidate gene approach) failed to identify genes mutated
in PCARP. In the current study, we performed targeted
DNA capture and high-throughput sequencing of the
entire 4.2 Mb AXPC1 locus and found a mutation in the
feline leukemia virus subgroup C cellular receptor 1 gene
(FLVCR1 [MIM 609144]). Subsequent Sanger-sequencing
analyses identified FLVCR1 mutations in unrelated
Spanish and French Canadian families with PCARP. The
study illustrates an approach that capitalizes on the power
and the broad applicability of resequencing technology to
find the causes of rare Mendelian disorders such as PCARP.Subjects and Methods
Human- and Animal-Research Approvals
Subjects were enrolled into research protocols approved by the
National Institute of Neurological Disorders and Stroke of the US
National Institutes of Health, the New York State Department of
Health, the Centre de Recherche du Centre Hospitalier de l’Uni-
versite´ de Montre´al, and the Oregon Health & Science University
institutional review boards. Informed consent was obtained
from all human research subjects. The Weill Cornell Medical
College Institutional Animal Care and Use Committees approved
the mouse work.
Clinical Evaluations
Detailed neurological and ophthalmic examinations were per-
formed in individuals belonging to families with PCARP. For
some individuals, additional clinical tests included brain and
spinal cord MRI, electromyography, nerve conduction velocities,
sural nerve biopsies, fundus photography, electroretinograms,
and visual-field measurements.
Linkage Analysis
Linkage analysis was reported previously for the American
(Figure 1) and Spanish (Figure 2) families.2,3 Samples from the
French Canadian family (Figure 3) were genotyped with the
Human 50K SNP Array (Affymetrix, CA, USA) via methods
described by the manufacturer. A microsatellite genome-wide
scan (deCODE Genetics, Iceland) was performed with the use of
500 polymorphic loci spaced at an average of 8 cM intervals.
The PCARP phenotype was analyzed as an autosomal-recessive
trait with 100% penetrance, a disease-gene frequency of 0.001,
and no phenocopies. Haplotypes were reconstructed in a single
section via themaximum-probabilitymethod of Genehunter v.2.1
DNA Capture Assay Design
Genomic coordinates 500 bpupstreamanddownstreamof the SNP
recombinants, rs10494961 and rs9308430, on chromosome 1
(corresponding to nucleotides [nt] 207,321,732-211,485,431 of
the March 2006 National Center for Biotechnology Information
[NCBI] build 36.1 of the Human Genome Assembly 18 [hg18])
were uploaded to the Agilent eArraywebsite (Agilent Technologies,644 The American Journal of Human Genetics 87, 643–654, NovembCA, USA). The following parameters were chosen: capture-probe
length¼ 120 bp, capture-probe tiling frequency ¼ 23, avoid over-
lap regions ¼ 20 bp, and avoid standard repeat masked regions.
Probes for both forward and reverse strands were included. In total,
57,628 probes were designed, covering 92% of the nucleotides in
RefSeq exons. Probe sequences were synthesized, amplified, and
conjugated with biotin as previously described.11
Genomic DNA-Fragment Library
Genomic DNA was extracted from human peripheral-blood
lymphocytes via the Puregene DNA Purification Kit (Gentra
Systems, MN, USA). Genomic DNA-fragment libraries were
prepared as described by the manufacturer (Illumina, CA, USA).
Five micrograms of each genomic DNA sample were fragmented
to less than 800 bp via nebulization. The overhangs resulting
from fragmentation were converted into blunt ends with the use
of T4 DNA polymerase and E. coli DNA polymerase I Klenow frag-
ment. Illumina single-end adapters were ligated to the ends of the
DNA fragments. Ligation products were purified on a 2% agarose
gel. Ten PCR cycles were performed with primers that anneal to
the ends of the adapters. The purified PCR-amplified fragment
libraries were quantified with the use of the PicoGreen dsDNA
Quantitation Assay with the Qubit Fluorometer (Invitrogen, CA,
USA). The size range was validated on the Agilent Technologies
2100 Bioanalyzer with the DNA 1000 Kit.
Target Enrichment System Capture Process
Size-selected libraries were denatured at 95C for 5 min and then
incubated with SureSelect (Agilent Technologies) Biotinylated
RNA library (‘‘baits’’) for 24 hr at 65C. RNA bait-DNA hybrids
were incubated with streptavidin-labeled Dynal (Invitrogen)
magnetic beads and captured onto a strongmagnet. After the beads
were washed, the RNA bait was digested until the remaining nucle-
otide was the targeted DNA of interest. The PCR product was puri-
fied by the Qiaquick PCR Purification Kit after 14 cycles of PCR
amplification. The targeted sample was quantified by the
PicoGreen assay in preparation for sequencing.
High-Throughput Sequencing
The protocols for the Illumina Single-Read Cluster Generation Kit
were used for cluster generation on the Cluster Station. With the
exception of preparing reagents and template DNA, all cluster-
generation steps were performed on the Cluster Station. The tar-
geted samples were diluted to 10 nmol and denatured with sodium
hydroxide. Ten picomoles of each target-enriched sample and Phix
controlwere loaded into separate lanesof the sameflowcell, hybrid-
ized onto the flow cell, and isothermally amplified. After lineariza-
tion, blocking, and primer hybridization, sequencing was per-
formed for 40 cycles on the Illumina 36 Cycle Sequencing Kit
version 4 with version 7.0 sequencing recipes. Raw image data
were converted into base calls via the Illumina pipeline version
1.6withdefaultparameters. Rigorousquality controlwasperformed
with theuseof data fromreports generatedby the Illuminapipeline.
Mapping, Coverage Uniformity, and SNV
and Indel Detection
All 40-bp-long reads weremapped to the reference human genome
sequence, hg18. Only reads mapping to a single location in the
genome were retained. Clonal reads (i.e., reads mapping at the
same genomic position and on the same strand) were collapsed
into a single read as described previously.12 Single-nucleotide
variant (SNV) detection was performed via the following
approach: For each nucleotide in the 4.2 Mb region, we calculateder 12, 2010
Figure 1. An Abridged Pedigree of an American Family with Recessively Inherited PCARP
A genome scan established linkage between PCARP and loci on chromosome 1q (AXPC1). To the left of each individual in each gener-
ation are seven chromosome 1q loci. Below each individual are reconstructed haplotypes for these loci. A star indicates a lack of homo-
zygosity in affected individuals 14, 18, and 23 for locusD1S249 and in individual 30 for locusD1S2141. Consanguineousmarriages have
calculated inbreeding coefficients over the bar uniting individuals. Black circles (females) and squares represent affected individuals with
PCARP (n ¼ 6). Three-quarters shading represents infants with areflexia and early retinal dystrophy (n ¼ 3). Obligate heterozygotes are
represented by symbols that are half shaded (n ¼ 10). Dark bars show parental haplotypes that segregate with PCARP. The figure is re-
printed with permission from Lippincott Williams & Wilkins.2the number of overlapping reads and determined which of these
reads showed a mismatch at that position compared to hg18.
Only positions with at least four overlapping reads were further
considered. Assuming that the large majority of mismatches
between the reads and hg18 are due to sequencing errors, we deter-
mined the probability of observing a given number of mismatches
at a given genomic position by chance, given the overall error rate
of the experiment. Assuming that mismatch counts follow a bino-
mial distribution, this probability is calculated by:
PðXRkÞ ¼
Xn
k

n
k

pkð1 pÞnk
where n represents the total number of reads overlapping with the
considered position, k represents the number of these reads that
contain a mismatch at that genomic position, and p is the overall
mismatch rate in the entire set of aligned reads. These probabilities
were adjusted for multiple-hypotheses testing via the Benjamini-
Hochberg approach, and a false discovery rate of 1% was used
for SNV calling. Short insertions and deletions (indels) were de-The Americantected with a similar approach: For each nucleotide in the 4.2
Mb region, we calculated the number of overlapping reads and
determined which of these reads showed a deletion or an insertion
of the same bp length at that position, compared to hg18 (inser-
tions and deletions were detected separately). The error model
we used to calculate p values and the correction for multiple
testing were the same as those used for SNVs. Variant calls were
compared between samples with homozygous affected (HA),
heterozygous (HET), and homozygous unaffected (HU) haplo-
types. Specifically, we searched for SNVs and indels that met the
following criteria: (1) present in both HA individuals in R 70%
of the reads (consistent with homozygous genetic variants); (2)
present in both HET individuals at a lower abundance, between
30% and 70% of the reads (consistent with heterozygous genetic
variants); and 3) not statistically detectable in both HU individuals
with the use of the error model described above. All SNVs and in-
dels present in the dbSNP (release 130) and in the 1000 Genomes
SNP database (March 2010 release; no indels were present in that
release) were filtered out. Custom computer programs and RefSeqJournal of Human Genetics 87, 643–654, November 12, 2010 645
Figure 2. Pedigree of a Spanish Family with PCARP
Fine mapping of the AXPC1 candidate interval in a Spanish family with PCARP refined the candidate region to 8.1 Mb by a recombina-
tion at D1S2735 in individual IV-10. The symbols are the same as in Figure 1 except that the crosshatched symbol represents an
unknown affection status and consanguineous marriages have double bars uniting individuals. An arrow points to the proband. The
question mark indicates that paternity could not be determined. The figure is reprinted with permission from John Wiley and Sons.3annotation downloaded from the UCSC Genome Browser data-
base were used to classify the remaining SNVs as missense,
nonsense, 50-untranslated region (UTR), 30-UTR, promoter, or in-
tronic. Indels were similarly annotated as placental mammal
PhastCons conservation scores for the hg18 nucleotides corre-
sponding to each variant in the UCSC Genome Browser annota-
tion database.
Sanger Sequencing
Intronic oligonucleotide primers that flanked the splice sites of
each FLVCR1 (NM_014053.2) coding region were used to amplify
its ten exons. The primer sequences and their positions on
chromosome 1 (NC_000001.10) are listed in Table S1, available
online. The PCR reactions contained 100 ng of genomic DNA in
a total volume of 25 ml with a final concentration of 0.8 mmol
of each primer, 0.25 mM of each dNTP, 10 mM Tris HCl (pH ¼
9.0), 50 mM KCl, 1.5 mM MgCl2, and 0.1 U of Taq polymerase
(New England Biolabs, MA, USA). The reactions were performed
in a 96-well microtiter plate on a Genius thermocycler (Techne,
NJ, USA). Amplification was carried out with an initial denatur-
ation step of 3 min at 96C followed by 35 cycles of denaturation
for 30 s at 96C, 15 s of annealing at 60C, and 30 s of extension at
72C. Samples were purified with ExoSAP-IT (USB, OH, USA) and
Sanger sequenced by standard methods (Genewiz, NJ, USA).
qPCR in Selected Mouse Brain Regions, Spinal Cord,
and Retina
Five C57BL/6 mice (Jackson Laboratories, ME, USA) were eutha-
nized at postnatal day 60. Deep-tissue punches of coronal brain
sections were processed by methods described previously.13 Eyes646 The American Journal of Human Genetics 87, 643–654, Novembwere removed, and the retina was dissected immediately and
frozen on dry ice before RNA extraction. Mice were skinned, evis-
cerated, and further dissected in 1.0 molar PBS at room tempera-
ture in a SLYGARD-coated dissection dish (Dow Corning, MI,
USA). After ventral laminectomy, the spinal cord was isolated
and segmented in 4 mm slices for the inclusion of coronal
segments from the thoracic and lumbar regions. Segments were
embedded in 4% low-melting agarose, and the dorsal horns,
including the dorsal columns, were isolated with a 22.5 stab
knife. Total RNA was extracted from all samples with the RNeasy
Lipid Tissue Mini Kit (QIAGEN, Germany). Two micrograms of
RNA were reverse transcribed to cDNA with the high-capacity
RNA-to-cDNA kit (Applied Biosystems, CA, USA). Quantitative
real-time reverse-transcriptase PCR (qPCR) experiments were per-
formed on an ABI PRISM 7000 Sequence Detection System with
the use of SYBR Green PCR Master Mix (Applied Biosystems) as
described previously.13,14 Flvcr1 (also known as Mfsd7b)-specific
primers (QIAGEN), amplifying a 115 bp product spanning exons
7 and 8 (NM_001081259.1), were used in the reactions. Primer-
amplification efficiency and product specificity were confirmed
by methods described previously.15 Flvcr1 mRNA amplification
was performed for 50 cycles (95C for 15 s, 60C for 30 s, 72C
for 30 s, extension time 72C for 10 min). The housekeeping
gene, b-actin (NM_007393.3) (forward primer 50-GAAATCGTG
CGTGACATCAAAG-30, nt 698–719; reverse primer 50-TGTAGTTT
CATGGATGCCACAG-30, nt 892–913), was used for normaliza-
tion. The DCT method was used to assess the relative expression
levels of Flvcr1 as described previously.15 The differences in the
mean mRNA levels (n ¼ 5) for each anatomical region were
compared by the Student’s t test.er 12, 2010
Figure 3. Pedigree of a French Canadian
Family with PCARP
The pedigree is from a family with four
members affected with PCARP, whose
founders emigrated from a region near
Bidart, France in the late 18th century to
the Gaspe´sie region of eastern Quebec,
Canada. Affected individuals IV-3, V-4,
and VI-2 shared a common homozygous
SNP haplotype in the AXPC1 region
between rs643930 and rs1434889. The
haplotype is different from the American
and Spanish families. The symbols are
the same as those in Figure 2.Results
Homozygosity Mapping and Linkage Analyses
The availability of extensive, accurate genealogical infor-
mation from an isolated, inbred, sectarian population of
Swiss German descent within the continental United
States permitted genetic analyses on a complex American
pedigree with nine affected individuals with PCARP
(Figure 1).1,2 Through a genome-wide scan of polymorphic
markers, the PCARP disease locus (AXPC1) in this Amer-
ican family was mapped to a 9.0 Mb region on chromo-
some 1q31-q32.2 Genetic-linkage studies in an unrelated
Spanish family with PCARP refined the AXPC1 candidate
region to 8.1 Mb (Figure 2).3 Further genetic mapping in
these two families with the use of the Human 50K SNP
Array (Affymetrix) delimited AXPC1 to a 4.2 Mb interval
between SNPs rs10494961 and rs9308430. A genome-
wide scan linked the French Canadian family (Figure 3)
to the AXPC1 locus with a LOD score of 3.0 on chromo-
some 1q32.2-q41. A recombinant present in individual
VI-2 delimited a candidate interval of 6.7 Mb between
loci D1S2692 and D1S237. SNP homozygosity mapping
delimited an interval of 5.3 Mb between SNPs rs643930
and rs1434889 on chromosome 1q32.2-q32.3 (data not
shown) but did not refine the minimal critical region
(MCR). Sanger sequencing of 25 of the 53 transcripts or
genes in the 4.2 Mb MCR, selected on the basis of known
or putative gene function in this candidate region, failed
to reveal disease-causing mutations.
High-Throughput Resequencing
Recognizing that a more comprehensive, unbiased
approach to identifying the genes mutated in PCARPThe American Journal of Human Genetwas needed, we used targeted DNA
capture and high-throughput se-
quencing to resequence the 4.2 Mb
AXPC1 interval in six individuals
from the aforementioned American
family (Figure 1). The subjects
included were two affected individ-
uals with an HA haplotype (individ-
uals 11 and 25), two unaffected
patients with an HET haplotype (indi-viduals 3 and 9), and two unaffected subjects with an
HU haplotype (individuals 21 and 31). Lymphocyte
genomic DNA from these individuals was captured via
a commercial hybridization-based approach (see Subjects
and Methods), and the captured products were sequenced
by Ilumina GAIIx single-end sequencing with the use of
one GAIIx lane per sample. The resulting 40-bp-long reads
were aligned to hg18 via BWA.16 Only unambiguously
mappable reads were retained. The total number of these
reads ranged from 26 to 29million per sample. The capture
efficiency was high; between 44% and 87% of all mapped
reads mapped to the captured AXPC1 region. The average
sequencing coverage in the captured region was high for
all samples, ranging from 1123 to 2313 (before clonal
read collapse). SNVs were then detected as described in
Subjects and Methods. The SNVs present in both HA
samples with a high allelic abundance (i.e., consistent
with a homozygous variant) were first identified and
matched with lower-abundance variants present in both
HET samples (i.e., consistent with a heterozygous variant).
The subset of these variants that were absent or present at
a nonsignificant level in both HU samples was then deter-
mined. This resulted in the identification of 540 SNVs.
Only 48 of these variants were not common, known poly-
morphisms in dbSNP release 130. Further filtering with the
use of the 1000 Genome database left nine of these 48 vari-
ants within the AXPC1 locus (Table 1). Only one variant,
located at chromosome 1 position 211,098,778 (hg18),
overlapped with a known exon (Figure S1). The SNV, an
A-to-G transition at position 361 (c.361A>G) of the coding
sequence of FLVCR1, predicted an asparagine-to-aspartic-
acid substitution (p.Asn121Asp). Alignment of the human
FLVCR1 sequence with its orthologs showed that thisics 87, 643–654, November 12, 2010 647
Table 1. Identification of a Gene Mutated in PCARP by Resequencing of the 4.2 Mb AXPC1 Locus
Samplesb
25 HA 11 HA 3 HET 9 HET 31 HU 21 HU
Nucleotidea Reads with Variant / Total Reads SNV Location Conservationc
207,488,200 35/35 11/11 4/8 8/25 1/16 1/22 C>T intergenic 0.989
210,852,233 69/69 25/25 5/12 20/49 1/30 0/28 G>T intron 1, ATF3 0.962
210,466,429 66/66 31/31 14/22 24/62 3/44 0/36 C>T intergenic 0.517
208,525,955 17/17 15/15 8/13 9/15 1/12 0/16 T>G intergenic 2.731
210,458,101 39/39 19/19 6/10 19/39 2/30 0/27 C>A intergenic 0.875
209,124,254 47/47 24/24 8/20 18/44 1/35 0/40 C>G intron 7, KCNH1 0.536
211,098,778 47/47 18/18 6/13 18/51 1/35 0/40 A>Gd CDS, FLVCR1 0.373
208,426,496 65/65 31/31 7/14 20/42 0/33 0/42 A>G intergenic 0.628
209,113,813 55/55 32/32 4/10 16/40 0/23 0/29 C>G intron 7, KCNH1 0.377
Abbreviations are as follows: CDS, coding sequence; HA, homozygous affected; HET, heterozygous; HU, homozygous unaffected; SNV, single nucleotide variant.
a The nucleotide position is according to the chromosome 1 NCBI36/hg18 assembly. Genomic coordinates are 0-based.
b Sample numbers correspond to individuals shown in Figure 1. The haplotype and affection status are as follows: Samples 25 and 11, homozygous affected;
samples 3 and 9, heterozygous; samples 31 and 21, homozygous unaffected.
c Conservation score based on multiple genome alignment data calculated by the PhastCons program.
d The SNV read-stack raw data is found in Figure S5.asparagine residue is highly conserved (Figure 4). The other
eight variants were within intergenic or intronic regions,
more than 2 kb away from known exons, and had low
PhastCons conservation scores, indicating that they were
unlikely to disrupt functional regulatory elements. We per-
formed a similar analysis for short indels and detected
three candidate short indels; however, all three indels
were in intergenic regions or in long introns (Table S2).
Sanger Sequencing
Sanger sequencing validated the FLVCR1 c.361A>Ghomo-
zygous mutation, which was found to segregate uniquely
in all affected individuals of the American family
with PCARP (Figures 5A and 5B). Sanger sequencing of
FLVCR1 in affected individuals in the Spanish family
with PCARP (Figure 2) identified a homozygous base pair
substitution in exon 1 (c.721G>A) causing an alanine-to-
threonine amino acid change in a highly conserved region
(p.Ala241Thr) (Figures 5C and 5D). Affected individuals in
a French Canadian family (Figure 3) also harbored a homo-
zygous sequence variant in exon 1 (c.574T>C) resulting in
a cysteine-to-arginine substitution in a highly conserved
region (p.Cys192Arg) (Figures 5E and 5F). The sequence
variants were found to segregate with disease in both the
Spanish and French Canadian families. All three identified
mutations occurred within the transmembrane-spanning
(TMS) segments 1, 3, and 5 of the FLVCR1 transporter
channel (Figure 4).17,18 Sanger sequencing of FLVCR1 in
two families fromWestern Europe (Figure 6) with a pheno-
type in keeping with PCARP failed to identify any
mutations, suggesting that PCARP may be genetically
heterogeneous, as is the case in the vast majority of
inherited retinal disorders. All mutations identified by
Sanger sequencing were not found in the dbSNP release648 The American Journal of Human Genetics 87, 643–654, Novemb130, 1000 Genomes, or HapMap databases as known
polymorphisms.
Clinical Evaluations of Families with PCARP
A summary of the clinical features in the American,
Spanish, and French Canadian families with PCARP and
FLVCR1 mutations is found in Table 2. Several privately
published genealogy books were analyzed to reconstruct
the American pedigree with the FLVCR1 homozygous
missense mutation, c.361A>G (p.Asn121Asp), that segre-
gates with the PCARP phenotype (Figure 1). The founder
was born in Switzerland in 1681 and moved to the
Netherlands when he was 17 years old. He immigrated to
colonial America in 1708. The large kindred spans ten
generations and has 3338 family members in the
unabridged genealogical tree. Affected individuals had the
childhood onset of RP accompanied by a ring scotoma,
a progressive loss of vision, proprioception, and generalized
areflexia. The cardinal feature of the movement disorder
was a sensory ataxia characterized by a loss of position
sensation, apallesthesia, and a lack of cerebellar signs.
Cognitive deficits or other significant motor or sensory
signs were absent in affected individuals. Two infants, at
ages 6 months and 1 year (Figure 1; individuals 13 and
23), had increased pigmentation in the periphery of the
retina and absent deep tendon reflexes at the ankle and
knee. The ophthalmoscopic examination, deep tendon
reflexes, and other neurological signs were normal in all
of the unaffected individuals. Peripheral ‘‘bone spicula’’
pigmentation with macular sparing characterized the fun-
doscopic pattern of the retinal dystrophy in affected indi-
viduals (Figure 7A). AnMRI scan of the spinal cord showed
evidence of posterior column degeneration in an affected
individual (individual 30; Figure 1) at age 39 (Figure 7B).er 12, 2010
Figure 4. Mutated FLVCR1 Amino Acid
Residues in PCARP
(A) Evolutionary conservation of FLVCR1
mutated residues and surrounding amino
acids. FLVCR1 encodes a cell-surface
protein predicted to contain 555 amino
acids, 12 transmembrane-spanning seg-
ments (TM1–TM5 and part of TM6 are
underlined), and six extracellular loops
(ECL 1–3 are shown). The amino acid resi-
dues mutated in PCARP (p.Asn121Asp,
p.Cys192Arg, and p.Ala241Thr), shown
in gray and bold, are all are located in
transmembrane segments. Homo sapiens,
man; Pan troglodytes, chimpanzee; Canis
lupus familiaris, dog; Bos taurus, domestic
cow; Mus musculus, house mouse; Gallus
gallus, chicken; Danio rerio, zebrafish.
(B) Partial FLVCR structure based on
UniProt Knowledgebase predictions show-
ing the location of the mutated residues
within the transmembrane segments.Affected members of a Spanish gypsy family (Figure 2)
were originally classified with a recessively inherited cere-
bellar ataxia and RP5 and were later reassessed for
PCARP.3,4 All affected individuals with the homozygous
FLVCR1 missense mutation, c.721G>A (p.Ala241Thr),
had visual disturbances caused by RP during the first
decade of life. Gait abnormalities were noticeable by the
second decade and slowly progressed over the life of the
affected individuals. Individual IV-14 exhibited a progres-
sive gait and limb ataxia beginning at age 14. A sural nerve
biopsy at age 35 showed a loss of large myelinated fibers
(Figure 7C).
All affected individuals from a French Canadian family
(Figure 3) with a homozygous FLVCR1missense mutation,
c.574T>C (p.Cys192Arg), had a childhood-onset heredi-
tary sensory neuropathy with RP and ataxia. The twoThe American Journal of Human Genetmales and two females were 16 to
51 years old. They presented initially
with delayed walking, orthopedic
deformities, scoliosis, and mild distal
weakness of intrinsic hand and foot
muscles. All affected individuals had
decreased fine touch and vibration
with proprioceptive loss in the feet.
Deep tendon reflexes were absent.
Walking became impossible in all
cases. The upper limb ataxia was
present but mild. Recurrent urinary
tract infections and incontinence
were other features.
Two families from Western Europe
had a PCARP-like phenotype without
mutations in FLVCR1 (Figure 6).
Siblings (two males and one female)
(Figure 6A) and a single affected
male patient from a second familyof patients (Figure 6B) had early-onset night blindness,
RP, unsteady gait, loss of position sense, and evidence of
sensory ataxia. In contrast to the other three families
with PCARP, all of the affected individuals had decreased
pain sensation in the hands and feet. These signs, noted
during the first or second decade, progressed over time.
An MRI scan of the head and thoracic spine was normal
for individual III-3 (Figure 6B). Other systemic findings
were scoliosis, gastrointestinal dysmotility, and campto-
dactyly. Sanger sequencing of FLVCR1 in individuals
III-5 (Figure 6A) and III-3 (Figure 6B) failed to reveal
mutations.
qPCR
To determine whether the selective pathologic features
of PCARP correlate with Flvcr1 expression, we examinedics 87, 643–654, November 12, 2010 649
Figure 5. Electropherograms of the three FLVCR1 missense mutations in families with PCARP
(A and B) Sanger sequencing confirms the homozygous c.361A>G (p.Asn121Asp) mutation in the American family.
(C–F) Sanger sequencing of FLVCR1 shows a homozygous c.721G>A (p.Ala241Thr) mutation in a Spanish family (C and D) and a
homozygous c.574T>C (p.Cys192Arg) mutation in a French Canadian family (E and F). The arrows indicate the base pair substitution.
The amino acid symbols are above the codon.wild-type mouse Flvcr1 mRNA levels in the brain
(neocortex, striatum, hippocampus, and cerebellum),
posterior column of the spinal cord, and retina by qPCR.Figure 6. Two Unrelated Western European Pedigrees with
a PCARP-like Phenotype and a Lack of FLVCR1 Mutations
(A) Three affected siblings (two males and one female) and (B)
a single affected male in two families from Western Europe with
PCARP. The symbols are the same as those in Figure 2.
650 The American Journal of Human Genetics 87, 643–654, NovembAs predicted, the Flvcr1 mRNA levels were most abundant
in the retina, followed by the posterior column of the
spinal cord and the cerebellum, as compared to the
neocortex, striatum, and hippocampus (Figure 8).Discussion
Proprioceptive impulses are relayed through ascending
large, fast-conducting, and medium-size myelinated nerve
fibers of the posterior columns of the spinal cord. Like the
retina, these fibers are somatotopically organized and
composed primarily of the central branches of dorsal root
ganglion cells (primary afferent fibers). The relationship
between vision and proprioception is poorly understood,
but vision can compensate for the loss of proprioception
through feed-forward and feedback mechanisms.19 Clini-
cally, this is illustrated in disorders such as PCARP, in
which injury to proprioceptive fibers results in ataxia
that appears, or is worsened, when the eyes are closed
(Romberg sign). At the molecular level, the nature of the
similarities between the posterior columns of the spinal
cord and the retina are uncharacterized. The presence of
interneurons and ganglion cells in both sensory systems
suggests that a gene mutated in PCARP is involved in an
age-related, developmental mechanism such as pro-
grammed cell death or apoptosis. To date, PCARP is the
sole human neurological disorder that is associated with
FLVCR1 mutations. Before this report, FLVCR1 was
thought to be exclusively associated with hematological
disorders such as Diamond-Blackfan syndrome (MIM
105650).20,21 Defective erythropoiesis and craniofacial
and limb deformities similar to this human hematological
disorder are present in Flvcr1 (also known as Mfsd7b) null
mice.21 The retinal phenotype of this knockout mouseer 12, 2010
Table 2. Clinical Characteristics of Patients with Mutations in FLCVR1
Individual
(Pedigree)
(FLVCR1
Mutation) Age (yr)
Initial
Eye
Findings
(Age)
Initial
Neurological
Signs
(Age) RP
Proprioceptive
Loss DTRs Other EMG/NCV Biopsies
11
(Figure 1)
(p.Asn121Asp)
9 night
blindness (4)
ataxia (3) yes yes absent GI
dysmotility
EMG: WNL;
sensory
nerve
conduction:
absent
14
(Figure 1)
(p.Asn121Asp)
11 night
blindness
(early
childhood)
ataxia
(childhood)
yes yes absent
18
(Figure 1)
(p.Asn121Asp)
8 night
blindness
(3-4)
ataxia
(3-4)
yes yes absent
24
(Figure 1)
(p.Asn121Asp)
19 night
blindness
(early
childhood)
ataxia
(childhood)
yes yes absent
25
(Figure 1)
(p.Asn121Asp)
17 night blindness
(early
childhood)
ataxia
(childhood)
yes yes absent
30
(Figure 1)
(p.Asn121Asp)
39 night
blindness
(early
childhood)
ataxia
(childhood)
yes yes absent camptodactyly,
scoliosis
EMG: WNL;
sensory
nerve
conduction:
absent
sural nerve: atrophy,
normal myelination,
axonal degeneration
(age 39); muscle:
normal.
13
(Figure 1)
(p.Asn121Asp)
6 mo pigmentary
retinopathy
(6 mo.)
areflexia yes absent
23
(Figure 1)
(p.Asn121Asp)
1 pigmentary
retinopathy
(1)
areflexia yes absent
IV-2
(Figure 2)
(p.Ala241Thr)
60 night
blindness
(infancy)
ataxia
(childhood)
yes yes absent cataracts
IV-10
(Figure 2)
(p.Ala241Thr)
48 visual loss
(12)
ataxia (1–2) yes yes absent cataracts
IV-14
(Figure 2)
(p.Ala241Thr)
18 visual loss
(18)
ataxia (14) yes yes absent dorsal
kyphosis
sural nerve: atrophy,
loss of large
myelinated
fibers (age 35)
(Figure 7C)
V-3
(Figure 2)
(p.Ala241Thr)
6 visual loss
(6)
ataxia (6) yes yes absent dorsal
kyphosis
V-4
(Figure 3)
(p.Cys192Arg)
14 pigmentary
retinopathy
(1.5)
delayed
walking (4)
yes yes absent neonatal
seizures,
osteomyelitis,
scoliosis, finger
contractures
sural nerve: atrophy,
normal myelination,
axonal degeneration
(age 1); muscle:
normal.
VI-2
(Figure 3)
(p.Cys192Arg)
13 pigmentary
retinopathy
(9 mo)
ataxia (1) yes yes absent occasional
fecal
incontinence
Abbreviations are as follows:; DTRs, deep tendon reflexes; EMG, electromyography; GI, gastrointestinal; NCV, nerve conduction velocities; RP, retinitis pigmen-
tosa; WNL, within normal limits.has not been reported to date. Although FLVCR1 is
expressed in the human and mouse brain,20 to our knowl-
edge its expression in the retina was unknown until we
showed its abundant expression by qPCR (Figure 8).The AmericanPrevious in situ hybridization studies in wild-type mice
showed Flvcr1mRNA expression in the cerebellum, hippo-
campus, and spinal cord (Figure S2). Our findings of high
levels in the retina and spinal cord suggest a correlationJournal of Human Genetics 87, 643–654, November 12, 2010 651
Figure 7. Phenotypic Features of Individuals with PCARP and
FLVCR1 Mutations
(A) Fundus photograph of individual 30 from the American family
(Figure 1) at age 39, showing typical bone-spicule pigmentation
and retinal vessel attenuation seen in RP.
(B) Axial MRI scan (TR-3000, TE-30, T1-150) with a white arrow
pointing toward an abnormal hyperintense signal in the posterior
aspect of the spinal cord of individual 30 (Figure 1) at age 39.
(C) A semithin cross-section of a sural nerve fascicle showing
severe loss of large myelinated fibers in individual IV-14 (Figure 2)
at age 35. The density of myelinated fibers was 850 per mm2, with
a complete loss of myelinated fibers having diameters larger than
8 mm. The two black arrows point to an area with preserved unmy-
elinated fibers (toluidine blue, 633 objective). Scale bar represents
10 mm.
Figure 8. Regional qPCR Studies of Flvcr1 mRNA Expression in
Mouse Neocortex, Striatum, Hippocampus, Cerebellum, Poste-
rior Column of the Spinal Cord, and Retina
Neocortex, CTX; striatum, STR; hippocampus, HC; cerebellum,
CRBM; posterior column of the spinal cord, PC; retina, RET. Flvcr1
mRNA levels in the RET are more than 3-fold higher than those in
the PC and five-fold higher than those in the CTX. Levels in the
PC are almost 3-fold higher than those in the CTX. Error bars
are represented by 5 SEM; **p < 0.001, *p < 0.01 as compared
to CTX.
652 The American Journal of Human Genetics 87, 643–654, Novembbetween the regional specificity of FLVCR1 mRNA expres-
sion and the selective degenerative pathology of PCARP.
Mutations in FLVCR1 most likely cause different pheno-
types based on the effect of mutations on its protein
domains. For example, mutations in the transmembrane
segments (Figure 4) lead to the PCARP phenotype, whereas
mutations in the extracellular loops affect the binding of
the feline leukemia virus.18 The lack of FLVCR1 mutations
in the Western European families with PCARP that we
studied suggests genetic heterogeneity. A phenotypic
feature that may distinguish individuals with and without
FLVCR1 mutations is impaired sensation in the distal
extremities. The presence of this stocking-and-glove poly-
neuropathy in PCARP families without FLVCR1mutations
suggests a more generalized disturbance in multiple
sensory neurons.
Mutations in the FLVCR1 paralog, FLVCR2 (MIM
610865), cause an autosomal-recessive prenatal lethal
disorder characterized by hydranencephaly and diffuse
ischemic injury to the brain and retina (Fowler syndrome
[MIM 225790]).22 Both FLVCR1 and FLVCR2 belong to
a large and diverse group of transporters called the major
facilitator superfamily (MFS).23 MFS transporters are
single-polypeptide secondary carriers capable of transport-
ing small solutes in response to chemiosmotic ion
gradients. MFS proteins contain 12 transmembrane alpha
helices connected by hydrophilic loops. FLVCR1 functions
as an exporter of cytoplasmic heme in erythrocyte precur-
sors,17 but its function in neurons is unknown. Heme,
a cyclic tetrapyrole containing a centrally chelated iron,
serves as the prosthetic group for hemoproteins such aser 12, 2010
neuroglobin (NGB [MIM 605304]) and hemoglobin. NGB
is a neuroprotective protein15 specific to neurons of
the central and peripheral nervous systems24–26 and the
retina.27 NGB mRNA expression is 100-fold higher in the
retina compared to the nervous system and is restricted
to the plexiform layers and the inner segments of the
photoreceptors.27 In general, the apoptotic changes in RP
occur initially in retinal photoreceptor cells, followed by
changes in ganglion cells.28 Inhibition of FLVCR1 cell-
surface expression induces apoptosis by the release of
cytochrome c and the activation of caspase 3.29 Consistent
with these observations, we hypothesize that the FLVCR1
missense mutations in PCARP perturb neuronal heme
transmembrane export, thereby abrogating the neuropro-
tective effects of NGB and initiating an apoptotic cascade
that results in the selective degeneration of photoreceptors
in the neurosensory retina and sensory neurons in the
posterior spinal cord.
This study describes a powerful and efficient resequenc-
ing approach that uses a few individuals from a single
family with a rare disorder to identify a gene that would
not have otherwise been selected as a plausible candidate
for a neurological disorder on the basis of its role in erythro-
poiesis. Identifying the underlying genetic causes of rare
disorders has profound implications in shedding light on
the molecular basis of fundamental developmental and
disease processes, improving genetic counseling and advice
regarding prognosis, and potentially leading to future
therapeutic interventions such as gene replacement
therapy. The progressive dysfunction over time of two
specific sensory modalities, vision and proprioception, in
PCARP illustrates the importance of such research in unrav-
eling the molecular mechanism of neuronal networks.
Studying the function of FLVCR1 in heme and iron metab-
olism and its relationship to sensory ataxia may unravel
fundamental neurodegenerative processes involved in Frie-
dreich ataxia and other disorders in which a disturbance of
iron homeostasis plays a central role in pathogenesis.Supplemental Data
Supplemental Data include two figures and two tables and can be
found with this article online at http://www.cell.com/AJHG/.Acknowledgments
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